Necrotizing fasciitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 32: Line 32:
:*[[Exotoxins|Extracellular exotoxins]]
:*[[Exotoxins|Extracellular exotoxins]]
::*[[Streptokinase]]
::*[[Streptokinase]]
::*streptolysin O and S
::*Streptolysin O and S
::*Streptodornase (DNase B)
::*Streptodornase (DNase B)
::*[[Hyaluronidase]]
::*[[Hyaluronidase]]
::*Streptococcal pyrogenic exotoxins
::*[[Streptococcal pyrogenic exotoxins]] (Spe)
:*[[Superantigen]]
:*[[Superantigen]]



Revision as of 19:59, 1 September 2016

Necrotizing fasciitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Necrotizing fasciitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Biopsy

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Necrotizing fasciitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Necrotizing fasciitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Necrotizing fasciitis pathophysiology

CDC on Necrotizing fasciitis pathophysiology

Necrotizing fasciitis pathophysiology in the news

Blogs on Necrotizing fasciitis pathophysiology

Directions to Hospitals Treating Necrotizing fasciitis

Risk calculators and risk factors for Necrotizing fasciitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Pathophysiology

The pathophysiology of necrotizing fasciitis is common to all types of NF but the speed of development and associated clinical features differs depending on the causative organisms.

  • The transmission of pathogens occurs through the following routes
  • External trauma
  • Direct spread from a perforated viscus (particularly colon, rectum, or anus)
  • Urogenital organ
  • Following transmission, the bacteria uses the entry site to invade the fascial planes which causes the wide spread necrosis of superficial fascia, subcutaneous fat, nerves, arteries and veins.

Pathogenesis

The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors.

Bacterial Factors

Type 1 NF

  • The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood.
  • It is thought that type 1 NF is caused by polymicrobial species that work together to enhance the spread of infection (Synergistic).

Type 2 NF

  • Adherence of bacteria to host tissue
  • Inhibition of phagocytosis



“Flesh-eating bacteria” is a misnomer, as the bacteria do not actually eat the tissue. They cause the destruction of skin and muscle by releasing toxins (virulence factors). These include streptococcal pyogenic exotoxins and other virulence factors. S. pyogenes produces an exotoxin known as a superantigen. This toxin is capable of activating T-cells non-specifically. This causes the over-production of cytokines that over-stimulate macrophages. The macrophages cause the actual tissue damage by releasing oxygen free radicals that are normally intended to destroy bacteria but are capable of damaging nearly any macromolecule they contact in the body.

References